Search Results
Dec 04, 2025, 09:03 ET Top Crunch Franchisee CR Fitness Goes Big with Four Texas One-Day Cyber Sale Events
enrollment fees, plus savings of up to $60 annually. The first 500 members to join at each location will receive exciting perks, including a free t-shirt, discounts on personal and small group training, and more! Each club will also be hosting an in-person Cyber Sale Party from 9:00 a.m. to 5:00 p.m.
More news about: CR Fitness Holdings, LLC.
Dec 04, 2025, 09:00 ET CREATING WEALTH IN ATLANTA: A-R-T & Associates 100% Employee-Owned with Support from Southeast Acquisition Capital & Allivate Impact Capital
their business to employee ownership, SEAC will help ensure that employees at A-R-T own the value they create," he said.Christopher Drew, former President of A-R-T & Associates, added, "The employees built A-R-T into the creative design firm it is today. As Stacy and I considered our options
More news about: Broadstreet Impact Services
Dec 04, 2025, 09:00 ET Tanabe Pharma America to Present Preclinical Research at MNDA on Edaravone's Potential Mechanisms in ALS
findings from a preclinical study using human induced pluripotent stem cell-derived motor neurons (iPSNs) from a patient with ALS harboring the TARDBP A382T mutation and from a healthy control donor. In this model, treatment with edaravone was observed to preserve neurite structures and reduce neuronal cell
More news about: Tanabe Pharma America
Dec 04, 2025, 09:00 ET SandboxAQ Achieves FedRAMP® Ready Status, Powering Enterprise Readiness Across the Defense and Public Sector
sectors. The company emerged from Alphabet Inc. as an independent, growth-backed company funded by leading investors including funds and accounts advised by T. Rowe Price Associates, Inc., IQT, US Innovative Technology Fund, S32, Hillspire Capital, Breyer Capital, Marc Benioff, Thomas Tull, Paladin Capital Group,
More news about: SandboxAQ
Dec 04, 2025, 08:46 ET Tiger Group Offers Rental-Ready Audiovisual Gear from Stray Angel Films
camera body(3) Canon C300 Mark II EF bodyLENSES(4) Canon Cinema Prime 24mm T/1.5 LF(3) Canon Cinema Prime 135mm T/2.2(4) Canon Cinema Prime 50mm T1.3 LF(1) Canon RF 28-70mm f/2 L USM lens(1) Canon RF 70-200mm f/2.8L IS USM lens(1)
More news about: Tiger Group
Dec 04, 2025, 08:44 ET Innatera and 42T Join Forces to Power the Next Wave of Intelligent Product Innovation
42 Technology (42T), a leading UK-based product development and manufacturing innovation consultancy, are partnering to accelerate neuromorphic adoption in consumer,
More news about: Innatera
Dec 04, 2025, 08:37 ET Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
U.S. in December 2025.About Cutaneous T-cell LymphomaCutaneous T-cell lymphoma is a type of cutaneous non-Hodgkin lymphoma (NHL) that comes in a variety of forms and is the most common type of cutaneous lymphoma. In CTCL, T-cells, a type of lymphocyte that plays a role in the immune
More news about: Citius Oncology, Inc.
Dec 04, 2025, 08:34 ET LIGHTSPEED 證券集體訴訟達成和解協議，發佈賠償申索公告
的安全網上申索系統提交予管理人。閣下僅可在無法使用互聯網時遞交紙質申索表格。紙質申索表格可透過郵遞或速遞寄送至管理人：CONCILIA SERVICES INC.1-5900 Andover Ave.Montréal (QC) H4T 1H5電話：1-888-350-7708
More news about: Concilia Services Inc.
Dec 04, 2025, 08:30 ET ImmunoGenesis Receives $10.8 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Accelerate the Clinical Development of IMGS-001 for Patients with Immune-Excluded Tumors with High Unmet Need
focuses on demonstrating safety and initial clinical benefit in multiple solid tumor cohorts characterized by a high degree of immune exclusion where CD8 T cells—the immune system's soldiers—are present but locked out of the tumor. IMGS-001 has been specifically engineered to drive clinical benefit in this
More news about: Immunogenesis Inc.
Dec 04, 2025, 08:30 ET Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium
inhibitors in breast cancer. #PS2-09-19Poster Session 2. December 10, 2025. 5:00 – 6:30 PM CSTCombined T and B Cell Signatures as Prognostic Biomarkers in Triple-Negative Breast Cancer (TNBC). #PS2-10-25Poster Session 2. December
More news about: Caris Life Sciences
Dec 04, 2025, 08:19 ET TELUS Announces Cash Tender Offers for Seven Series of Debt Securities
Offer to Purchase, TELUS disclaims any intention or obligation to update or revise forward-looking statements.About TELUSTELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over C$20 billion in annual revenue
More news about: TELUS Corporation
Dec 04, 2025, 08:13 ET 新橋生物宣佈將在ESMO-IO大會上公佈Ragistomig擴展性1期臨床數據
Bio聯合開發，是一款差異化的新型雙特異性抗體，其整合了作為腫瘤接合器的單鏈、Fc沉默的PD-L1片段和作為條件性T細胞激活劑的4-1BB片段。它採用ABL Bio的「Grabody-T」雙特異性抗體平台技術開發，旨在克服PD-(L)1抑制劑的耐藥性，並僅在PD-L1表達陽性的腫瘤細胞存在時才刺激4-1BB激活，以最大限度地降低脫靶毒性風險。臨床前研究表明，該雙特異性抗體顯示出比其單一組分抗體更優的抗腫瘤活性。一項1期劑量擴展研究（NCT04762641）目前正在美國及韓國進行。該研究的主要終點是確定ragistomig的劑量限制性毒性和不良事件特徵，並觀察客觀緩解率、藥物代謝動力學和免疫原性特徵以及其他次要終點。關於新橋生物新橋生物是一家
More news about: 新橋生物
Dec 04, 2025, 08:12 ET UCB shares leading scientific research and advances at American Epilepsy Society Annual Meeting
Becky MaloneT [email protected]
More news about: UCB
Dec 04, 2025, 08:00 ET Mynd Immersive and Select Rehabilitation Expand Partnership to 500+ Senior Care Communities, Establishing the Largest Immersive Therapeutics Dataset in U.S. Healthcare
therapy providers. Together, the two organizations will accelerate the deployment of MyndXR™, the company's flagship therapeutic platform powered by AT&T 5G, across more than 500 senior living communities nationwide, including many of the sector's largest operators. This expansion represents
More news about: MyndVR Inc.
Dec 04, 2025, 08:00 ET Trinity Capital Inc. Provides Equipment Financing to Sortera Technologies to Scale AI-Powered Upcycling Innovation
development. To date, Sortera has attracted notable investors including RA Capital Management-Planetary Health, certain funds and accounts advised by T. Rowe Price Associates, Inc., the Mineral Resources Group, a part of Mitsubishi Corporation's Business Incubation Unit, Macquarie GIG Energy Transition
More news about: Trinity Capital Inc.
Dec 04, 2025, 07:19 ET 라이트스피드 증권 집단 소송 합의 공지문
허용된다. 종이 청구서는 우편이나 택배로 합의 대행사(아래의 연락처 정보 참조)에 보내면 된다.CONCILIA SERVICES INC.1-5900 Andover Ave.Montréal (QC) H4T 1H5전화: 1-888-350-7708
More news about: Concilia Services Inc.
Dec 04, 2025, 07:03 ET ANKÜNDIGUNG DES VERGLEICHS DER SAMMELKLAGE IN BEZUG AUF LIGHTSPEED-WERTPAPIERE
per Post oder Kurier an den Verwalter geschickt werden:CONCILIA SERVICES INC.1-5900 Andover Ave.Montréal (QC) H4T 1H5Tel: 1-888-350-7708
More news about: Concilia Services Inc.
Dec 04, 2025, 07:01 ET Iridium Appoints Louis Alterman to Board of Directors
solutions provider. He previously served on the board of CareerBuilder from 2018 to 2022, and from 1999 to 2003, he worked at BellSouth (now part of AT&T).He received a bachelor's degree in business administration from the University of Georgia, a Master of Business Administration from Emory University's
More news about: Iridium Communications Inc.
Dec 04, 2025, 07:01 ET Iridium Appoints Louis Alterman to Board of Directors
solutions provider. He previously served on the board of CareerBuilder from 2018 to 2022, and from 1999 to 2003, he worked at BellSouth (now part of AT&T).He received a bachelor's degree in business administration from the University of Georgia, a Master of Business Administration from Emory University's
More news about: Iridium Communications Inc.
Dec 04, 2025, 07:00 ET Jack T. Diamond Joins GHC Industries as Principal & Chief Strategy Officer
CLEVELAND, Dec. 4, 2025 /PRNewswire/ -- GHC Industries is proud to announce the appointment of Jack T. Diamond as Chief Strategy Officer, marking a pivotal milestone in the company's continued expansion across its healthcare vertical. Mr. Diamond will
More news about: GHC Industries
Dec 04, 2025, 06:55 ET AVIS DE REGLEMENT DE LA PROCEDURE DE RECOURS COLLECTIF RELATIVE AUX TITRES LIGHTSPEED
de messagerie à l'administrateur à l'adresse suivanteCONCILIA SERVICES INC.1-5900 Andover Ave.Montréal (QC) H4T 1H5Tél : 1-888-350-7708
More news about: Concilia Services Inc.
Dec 04, 2025, 06:30 ET HORMEL FOODS REPORTS FOURTH QUARTER AND FULL-YEAR FISCAL 2025 RESULTS
from non-GAAP measures used by other companies.Transform and Modernize (T&M) InitiativeIn the fourth quarter of fiscal 2023, the Company announced a multi-year T&M initiative. In presenting non-GAAP measures, the Company adjusts for (i.e., excludes) expenses
More news about: Hormel Foods Corporation
Dec 04, 2025, 06:00 ET AvenCell Therapeutics Announces IND Clearance and EMA Approval of Clinical Trial Application (CTA) for the QUADvance Study, a Phase I/II trial evaluating AVC-203, a Novel Allogeneic CD19/CD20 CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-cell malignancies
CAR-T candidate designed to target and eliminate cells expressing receptors CD19 and/or CD20, which are known to be expressed in nearly all B-cell malignancies."We are excited to build on the early success and promising activity and safety of our ongoing clinical program of allogeneic CAR-T in
More news about: AvenCell Therapeutics, Inc.
Dec 04, 2025, 06:00 ET NOTICE OF THE SETTLEMENT OF THE CLASS ACTION PROCEEDINGS RELATING TO LIGHTSPEED SECURITIES
may be sent by mail or courier to the Administrator at:CONCILIA SERVICES INC.1-5900 Andover Ave.Montréal (QC) H4T 1H5Tel: 1-888-350-7708
More news about: Concilia Services Inc.
Dec 04, 2025, 06:00 ET NOTICE OF THE SETTLEMENT OF THE CLASS ACTION PROCEEDINGS RELATING TO LIGHTSPEED SECURITIES
may be sent by mail or courier to the Administrator at:CONCILIA SERVICES INC.1-5900 Andover Ave.Montréal (QC) H4T 1H5Tel: 1-888-350-7708
More news about: Concilia Services Inc.